BlackBerry Ltd, AcelRx & Benzinga's Top PreMarket Losers
AcelRx Pharmaceuticals (NASDAQ: ACRX) shares slipped 10.71% to $6.00 in pre-market trading after the company offered a regulatory update for Zalviso.
Finish Line (NASDAQ: FINL) fell 8.19% to $27.00 in pre-market trading after the company reported downbeat second-quarter results.
BlackBerry Ltd (NASDAQ: BBRY) shares dropped 2.55% to $9.55 in pre-market trading. The company reported a narrower-than-expected second-quarter loss. However, the company's revenue missed analysts' estimates.
Philip Morris International (NYSE: PM) dropped 0.60% to $83.20 in pre-market trading. Analysts at Bank of America downgraded Philip Morris International from Buy to Neutral and lowered the target price to $87.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.